Bax inhibition protects against free fatty acid-induced lysosomal permeabilization

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Feldstein, Ariel E ^a   Werneburg, Nathan W ^b   Li, Zhengzheng ^a   Bronk, Steven F ^b   Gores, Gregory J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Mayo Clinic   (United States)

Author keywords

Bax; Bcl 2 family; Cathepsin B; Lysosomes; Nonalcoholic fatty liver disease

Indexed keywords

CASPASE; CATHEPSIN B; CERAMIDE; FATTY ACID; PALMITIC ACID; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PERMEABILIZATION; CONTROLLED STUDY; LIVER CELL; LIVER FUNCTION; LYSOSOME; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; FATTY ACIDS, NONESTERIFIED; HEPATOCYTES; LYSOSOMES; MALE; MICE; MICE, INBRED C57BL; PALMITIC ACID;

EID: 33646891970     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00509.2005     Document Type: Article

References (39)

1. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, and Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
3. Browning JD and Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152, 2004.
4. Brunt EM and Tiniakos DG. Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 16: 691-707, 2002.
5. Clark JM, Brancati FL, and Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 122: 1649-1657, 2002.
6. Cory S and Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
7. Day C and Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 17, Suppl 3: S377-S384, 2002.
8. Day CP and James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
9. Diehl AM. Fatty liver, hypertension, and the metabolic syndrome. Gut 53: 923-924, 2004.
10. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, and Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443, 2003.
11. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, and Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39: 978-983, 2003.
12. Feldstein AE and Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 10: 3093-3099, 2005.
13. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, and Gores GJ. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40: 185-194, 2004.
14. Friedman JM. Obesity in the new millennium. Nature 404: 632-634, 2000.
15. Guicciardi ME, Leist M, and Gores GJ. Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
16. Harrison SA and Neuschwander-Tetri B. A Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8: 861-879, 2004.
17. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R, Weber T, Saftig P, Peters C, Brunner J, Kronke M, and Schutze S. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18: 5252-5263, 1999.
18. Hsu YT and Youle RJ. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273: 10777-10783, 1998.
19. Hsu YT and Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272: 13829-13834, 1997.
20. Kwon G, Pappan KL, Marshall CA, Schaffer JE, and McDaniel ML. cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells. J Biol Chem 279: 8938-8945, 2004.
21. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, and Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100: 3077-3082, 2003.
22. Listenberger LL and Schaffer JE. Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 12: 134-138, 2002.
23. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, and Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923, 2003.
24. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, and McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419, 1999.
25. Mishra R and Simonson MS. Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G. Cardiovasc Diabetol 4: 2, 2005.
26. Nehra V, Angulo P, Buchman AL, and Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 46: 2347-2352, 2001.
27. Roberts LR, Kurosawa H, Bronk SF, Fesmier PJ, Agellon LB, Leung WY, Mao F, and Gores GJ. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113: 1714-1726, 1997.
28. Sawada M, Hayes P, and Matsuyama S. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 5: 352-357, 2003.
29. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287, 2003.
30. Shimabukuro M, Ohneda M, Lee Y, and Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 100: 290-295, 1997.
31. Shimabukuro M, Zhou YT, Levi M, and Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 95: 2498-2502, 1998.
32. Ulloth JE, Casiano CA, and De Leon M. Palmitic and stearic fatty acids induce caspase-dependent and -independent cell death in nerve growth factor differentiated PC12 cells. J Neurochem 84: 655-668, 2003.
33. Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 14: 398-403, 2003.
34. Unger RH. Lipotoxic diseases. Annu Rev Med 53: 319-336, 2002.
35. Werneburg N, Guicciardi ME, Yin XM, and Gores GJ. TNF-α-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physiol 287: G436-G443, 2004.
36. Werneburg NW, Guicciardi ME, Bronk SF, and Gores GJ. Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 283: G947-G956, 2002.
37. Wieckowska A and Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 17: 636-641, 2005.
38. Yoshida T, Tomioka I, Nagahara T, Holyst T, Sawada M, Hayes P, Gama V, Okuno M, Chen Y, Abe Y, Kanouchi T, Sasada H, Wang D, Yokota T, Sato E, and Matsuyama S. Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem Biophys Res Commun 321: 961-966, 2004.
39. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, and Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.